---
title: "Amgen snaps after six straight sessions of gains"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273555847.md"
description: "Amgen snaps after six straight sessions of gains"
datetime: "2026-01-23T21:13:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273555847.md)
  - [en](https://longbridge.com/en/news/273555847.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273555847.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/273555847.md) | [繁體中文](https://longbridge.com/zh-HK/news/273555847.md)


# Amgen snaps after six straight sessions of gains


### Related Stocks

- [Amphastar Pharmaceuticals, Inc. (AMPH.US)](https://longbridge.com/en/quote/AMPH.US.md)
- [iShares US Pharmaceuticals ETF (IHE.US)](https://longbridge.com/en/quote/IHE.US.md)
- [First Trust NYSE Arca Biotech ETF (FBT.US)](https://longbridge.com/en/quote/FBT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/en/quote/IBBQ.US.md)
- [ProShares Ultra Nasdaq Biotechnology (BIB.US)](https://longbridge.com/en/quote/BIB.US.md)
- [Vanguard Health Care ETF (VHT.US)](https://longbridge.com/en/quote/VHT.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/en/quote/IBB.US.md)
- [Amgen Inc. (AMGN.US)](https://longbridge.com/en/quote/AMGN.US.md)
- [State Street®HlthCrSelSectSPDR®ETF (XLV.US)](https://longbridge.com/en/quote/XLV.US.md)
- [ALPS Medical Breakthroughs ETF (SBIO.US)](https://longbridge.com/en/quote/SBIO.US.md)
- [State Street® SPDR® S&P® Biotech ETF (XBI.US)](https://longbridge.com/en/quote/XBI.US.md)
- [ARK Genomic Revolution ETF (ARKG.US)](https://longbridge.com/en/quote/ARKG.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/en/quote/PBE.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/en/quote/BBH.US.md)
- [iShares Global Healthcare ETF (IXJ.US)](https://longbridge.com/en/quote/IXJ.US.md)

## Related News & Research

- [Dimensional Fund Advisors LP Raises Holdings in Amgen Inc. $AMGN](https://longbridge.com/en/news/277759831.md)
- [Amphastar Q4 revenue misses estimates](https://longbridge.com/en/news/277102773.md)
- [Kyowa Kirin discontinues ongoing trials of rocatinlimab](https://longbridge.com/en/news/277766830.md)
- [BUZZ-MAIA Biotechnology plunges after $30 million share sale](https://longbridge.com/en/news/277605454.md)
- [Arrowhead Pharmaceuticals Teases 2026 Catalysts, Waylivra Launch Momentum at TD Cowen Conference](https://longbridge.com/en/news/277861194.md)